PerturbRx
Lead research directionA framework for learning intervention-induced biological state transitions from perturbational data and transferring those dynamics toward patient-level drug-response prediction.
Research portfolio
My work centers on learning how biological systems respond to therapeutic interventions, and on transferring those models across cellular, molecular, and patient contexts.
Featured research
A framework for learning intervention-induced biological state transitions from perturbational data and transferring those dynamics toward patient-level drug-response prediction.
A heterogeneous graph model connecting drugs, cell lines, and genes to predict response while producing gene-level, mechanism-oriented attributions.
A multi-agent framework for integrating heterogeneous and conflicting biomedical evidence for drug-target interaction prediction and therapeutic discovery.
Earlier & collaborative work
Graph importance propagation for interpretable drug-response prediction, incorporating prior biological relationships into feature importance learning.
A bi-graph convolutional approach leveraging cell and gene similarities for single-cell transcriptome imputation.
A cross-database platform for exploring pharmacogenomic relationships across patient-derived cancer cell-line datasets.
Investigation of TRPM4 as a predictive biomarker and mechanistic driver of Acetalax activity in prostate cancer.
Resources
Reusable utilities for evaluation, reproducibility, molecular fingerprints, biomedical identifier mapping, caching, PMC XML processing, and scientific visualization.
Exploratory questions and forward-looking directions in therapeutic-response modeling, biological dynamics, and biomedical AI.